MONTREAL, Jan. 26, 2021 /PRNewswire/ – Caprion-HistoGeneX, a leading international company of specialised precision drugs laboratory companies to the biopharmaceutical business, is pleased to announce its new corporate name, CellCarta, and model identity.
The new title for the Montreal-headquartered company stems from the 2019 mix of agreement study group Caprion Biosciences, which specializes in immunology and proteomics services, and HistoGeneX, a company of histopathology and genomics services based mostly in Antwerp. Just lately, CellCarta further more expanded its scientific capabilities and geographic presence by means of the acquisitions of Nova Scotia-dependent Clinical Logistics Inc. and California-dependent Mosaic Laboratories LLC. As a end result, CellCarta is properly positioned to provide the world wide medical demo prerequisites of its pharmaceutical and bio-tech purchasers with condition-of-the-artwork services in the United States, Canada, Europe and China. CellCarta is backed by Arsenal Cash Companions.
The title CellCarta is motivated by the Magna Carta, a image of specific liberty, and is intended to evoke the company’s mission of mapping the content and function of human cells to permit and speed up the evolution of customized precision medicine.
“Our mission is to be the global partner of decision for biopharmaceutical businesses looking for precision medication answers to assistance assure a much healthier future for us all,” mentioned Martin LeBlanc, CEO of CellCarta. “By uniting our diverse groups of scientists throughout the world underneath a common manufacturer identity, we goal to articulate a solitary message aligned with our shared established of essential values centered on scientific excellence, a collaborative mindset and a commitment to produce high high quality success to our companions. It also further more reinforces our dedication to provide our customers with a broad and built-in established of expert services underneath a single group.”
The new manufacturer id was produced in conjunction with BrandBourg, a Canadian consultancy company specializing in brand name tactic and manufacturer id.
CellCarta’s visible identification is meant to be reminiscent of a map or puzzle representing the distinctions among human cells. It is more meant to convey a brand character that is innovative, trustworthy and embodies scientific management.
“We wished to create a brand that is exceptional in the market, appropriate to our clientele and inspiring to our employees about the environment,” explained Nick Wright, President and COO of CellCarta. “CellCarta embodies every little thing we do, which is about mapping dissimilarities concerning cells and finally among people, so that our companions can acquire far better and extra focused therapies.”
David Spaight, Executive Chairman of CellCarta and an Arsenal Operating Husband or wife, included, “By uniting underneath a single manufacturer id, CellCarta is sending a signal that its rapid expansion through acquisitions and natural development has resulted in a marketplace-top business that is greater than the sum of its components. The ongoing success of CellCarta exemplifies Arsenal’s ‘Strategic Firm Building’ solution that focuses on growing a company’s option presenting, elevating its industry position, and compounding its growth.”
The adhering to movie even further describes CellCarta’s new brand name identification: www.cellcarta.com
CellCarta is a main supplier of specialized precision medicine laboratory expert services to the biopharmaceutical sector. Leveraging its integrated analytical platforms in immunology, histopathology, proteomics and genomics, as perfectly as connected specimen collection and logistics services, CellCarta supports the full drug growth cycle, from discovery to late-stage medical trials. The organization operates globally with with more than 700 staff members in its nine services positioned in Canada, Usa, Belgium, Australia, and China. For more details: www.cellcarta.com
About Arsenal Money Associates
Arsenal is a foremost non-public fairness company that specializes in investments in middle-sector health care and industrials providers. Considering that its inception in 2000, Arsenal has raised institutional equity expenditure money of $5.3 billion, has accomplished a lot more than 200 platform and incorporate-on investments, and accomplished far more than 30 realizations. Arsenal health care providers concentration on bettering essential healthcare processes and scientific requirements foremost to enhanced results for sufferers. The company performs with administration teams to construct strategically critical corporations with foremost market place positions, large growth and high benefit-include. For far more facts: www.arsenalcapital.com
See first material to down load multimedia: http://www.prnewswire.com/news-releases/precision-drugs-chief-caprion-histogenex-rebrands-as-cellcarta-301214588.html
Source Caprion Biosciences